JAMA Netw Open
Treatment of Opioid Use Disorder in Pregnant Women via Telemedicine: A Nonrandomized Controlled Trial.
Guille C, Simpson AN, Douglas E, Boyars L, Cristaldi K, McElligott J, Johnson D, Brady K
There are high rates of maternal and newborn morbidity and mortality associated with opioid use disorder (OUD). Integrating OUD treatment in obstetric ...
Read More
Source: PubMed
J. Pediatr. 2020 Jan 24
Neurodevelopmental Outcomes of Neonates Randomized to Morphine or Methadone for Treatment of Neonatal Abstinence Syndrome.
Czynski AJ, Davis JM, Dansereau LM, Engelhardt B, Marro P, Bogen DL, Hudak ML, Shenberger J, Wachman EM, Oliveira EL, Lester BM
To evaluate the effects of pharmacologic treatment of neonatal abstinence syndrome on neurodevelopmental outcome from a randomized, controlled trial. ...
Read More
Source: PubMed
J Obstet Gynaecol Can 2020 Jan 13
Infant and Maternal Outcomes for Women Who Experience Imprisonment in Ontario, Canada: A Retrospective Cohort Study.
Carter Ramirez A, Liauw J, Costescu D, Holder L, Lu H, Kouyoumdjian FG
To describe the population-level risk of infant and maternal outcomes for women who experience imprisonment and compare outcomes with the general popu ...
Read More
Source: PubMed
Pediatr. Res. 2020 Jan 14
N-acetylcysteine mitigates acute opioid withdrawal behaviors and CNS oxidative stress in neonatal rats.
Ward P, Moss HG, Brown TR, Kalivas P, Jenkins DD
Neonatal abstinence syndrome (NAS) is a significant problem. Opioid withdrawal induces oxidative stress and disrupts glutamate and glutathione homeost ...
Read More
Source: PubMed
Hosp Pediatr
An Update on the Burden of Neonatal Abstinence Syndrome in the United States.
Ramphul K, Mejias SG, Joynauth J
To provide an estimate on the most recent burden of neonatal abstinence syndrome (NAS) in the United States. ...
Read More
Source: PubMed
